Fecal water genotoxicity is predictive of tumor-preventive activities by inulin-like oligofructoses, probiotics (Lactobacillus rhamnosus and Bifidobacterium lactis), and their synbiotic combination - PubMed (original) (raw)
Fecal water genotoxicity is predictive of tumor-preventive activities by inulin-like oligofructoses, probiotics (Lactobacillus rhamnosus and Bifidobacterium lactis), and their synbiotic combination
Annett Klinder et al. Nutr Cancer. 2004.
Abstract
The measurement of fecal water genotoxicity in human colon cells could be a useful biomarker to study effects of diet in the colon. Here we assessed aqueous fecal extracts of samples from a chronic study with rats fed prebiotics, probiotics, and their combination. Treatments were maltodextrins (controls), inulin/oligofructoses (prebiotic), Lactobacillus rhamnosus, and Bifidobacterium lactis (probiotics) or both (synbiotic). Azoxymethane (AOM) was administered to initiate tumors. Rat feces were collected at 0 and 10 days and 2, 4, and 8 mo, and cecal contents were collected at 8 mo. Aqueous phases were prepared and tested for genotoxicity in HT29 colon cells using the comet assay. The studied types of intervention reduced fecal and cecal genotoxicity. DNA damage by samples from AOM-treated, tumor-free rats was significantly lower than from tumor-bearing animals, especially after 4 mo of synbiotic and prebiotic interventions. Inulin-based diets reduced exposure to genotoxins in the feces, directly reflecting the reported reduction of tumor incidence in these animals. Evidence is provided for the validity of this measurement as a biomarker of chemoprevention because 1) fecal water genotoxicity reflected genotoxic exposure in the cecum, 2) tumor incidence and fecal genotoxicity were directly related, and 3) these interventions reduced tumor risks by reducing exposure to genotoxins in the gut.
Similar articles
- Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats.
Femia AP, Luceri C, Dolara P, Giannini A, Biggeri A, Salvadori M, Clune Y, Collins KJ, Paglierani M, Caderni G. Femia AP, et al. Carcinogenesis. 2002 Nov;23(11):1953-60. doi: 10.1093/carcin/23.11.1953. Carcinogenesis. 2002. PMID: 12419846 - Effects of lycopene, synbiotic and their association on early biomarkers of rat colon carcinogenesis.
Dias MC, Vieiralves NF, Gomes MI, Salvadori DM, Rodrigues MA, Barbisan LF. Dias MC, et al. Food Chem Toxicol. 2010 Mar;48(3):772-80. doi: 10.1016/j.fct.2009.12.003. Epub 2009 Dec 21. Food Chem Toxicol. 2010. PMID: 20026158 - Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats.
Le Leu RK, Hu Y, Brown IL, Woodman RJ, Young GP. Le Leu RK, et al. Carcinogenesis. 2010 Feb;31(2):246-51. doi: 10.1093/carcin/bgp197. Epub 2009 Aug 20. Carcinogenesis. 2010. PMID: 19696163 - Food-based strategies to modulate the composition of the intestinal microbiota and their associated health effects.
Bosscher D, Breynaert A, Pieters L, Hermans N. Bosscher D, et al. J Physiol Pharmacol. 2009 Dec;60 Suppl 6:5-11. J Physiol Pharmacol. 2009. PMID: 20224145 Review. - Prebiotics and probiotics: are they functional foods?
Roberfroid MB. Roberfroid MB. Am J Clin Nutr. 2000 Jun;71(6 Suppl):1682S-7S; discussion 1688S-90S. doi: 10.1093/ajcn/71.6.1682S. Am J Clin Nutr. 2000. PMID: 10837317 Review.
Cited by
- Substituting meat for mycoprotein reduces genotoxicity and increases the abundance of beneficial microbes in the gut: Mycomeat, a randomised crossover control trial.
Farsi DN, Gallegos JL, Koutsidis G, Nelson A, Finnigan TJA, Cheung W, Muñoz-Muñoz JL, Commane DM. Farsi DN, et al. Eur J Nutr. 2023 Apr;62(3):1479-1492. doi: 10.1007/s00394-023-03088-x. Epub 2023 Jan 18. Eur J Nutr. 2023. PMID: 36651990 Free PMC article. Clinical Trial. - Gut microbial differences in breast and prostate cancer cases from two randomised controlled trials compared to matched cancer-free controls.
Smith KS, Frugé AD, van der Pol W, Caston NE, Morrow CD, Demark-Wahnefried W, Carson TL. Smith KS, et al. Benef Microbes. 2021 Jun 15;12(3):239-248. doi: 10.3920/BM2020.0098. Epub 2021 Apr 1. Benef Microbes. 2021. PMID: 33789551 Free PMC article. - Functional yogurt aims to protect against the aflatoxin B1 toxicity in rats.
Abdel-Salam AM, Badr AN, Zaghloul AH, Farrag ARH. Abdel-Salam AM, et al. Toxicol Rep. 2020 Oct 21;7:1412-1420. doi: 10.1016/j.toxrep.2020.10.012. eCollection 2020. Toxicol Rep. 2020. PMID: 33102145 Free PMC article. - Genoprotective Properties and Metabolites of β-Glucan-Rich Edible Mushrooms Following Their In Vitro Fermentation by Human Faecal Microbiota.
Boulaka A, Christodoulou P, Vlassopoulou M, Koutrotsios G, Bekiaris G, Zervakis GI, Mitsou EK, Saxami G, Kyriacou A, Zervou M, Georgiadis P, Pletsa V. Boulaka A, et al. Molecules. 2020 Aug 4;25(15):3554. doi: 10.3390/molecules25153554. Molecules. 2020. PMID: 32759726 Free PMC article. - Prebiotics: tools to manipulate the gut microbiome and metabolome.
Enam F, Mansell TJ. Enam F, et al. J Ind Microbiol Biotechnol. 2019 Oct;46(9-10):1445-1459. doi: 10.1007/s10295-019-02203-4. Epub 2019 Jun 14. J Ind Microbiol Biotechnol. 2019. PMID: 31201649 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical